Brush Buddies Crayola Anticavity Fluoride Strawberry

Description

No description information is available.

Uses and Indications

This drug is indicated for the protection of teeth against cavities.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 6 years and older should use the product daily after brushing their teeth with toothpaste. Prior to use, it is essential to rinse the mouth thoroughly to remove any residual toothpaste. The bottle must be shaken well before each use; the cap should be twisted and removed to access the solution.

For administration, 15 ml of the rinse should be measured and used for rinsing or gargling for a duration of 30 seconds, after which the solution must be spat out. It is critical to avoid swallowing the rinse. Additionally, patients should refrain from eating or drinking for 30 minutes following the use of the rinse to ensure optimal effectiveness. Caregivers should supervise children as necessary during this process.

For children under 6 years of age, it is recommended to consult with a dentist or doctor prior to use to ensure safety and appropriateness of the product.

Contraindications

Use is contraindicated in children under 6 years of age due to the potential risk of accidental ingestion. In the event of accidental swallowing beyond the recommended use for rinsing, it is imperative to seek professional medical assistance or contact a Poison Control Center immediately.

Warnings and Precautions

It is imperative to keep this product out of reach of children under 6 years of age to prevent accidental ingestion and potential harm.

In the event of accidental ingestion of an amount exceeding that which is typically used for rinsing, it is crucial to seek professional medical assistance or contact a Poison Control Center immediately. Prompt action is essential to ensure the safety and well-being of the individual involved.

Side Effects

There are no specific adverse reactions or side effects listed for the medication. Clinical trials and postmarketing experiences have not identified any notable adverse reactions associated with its use. As such, healthcare professionals should continue to monitor patients for any unexpected effects during treatment.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Brush Buddies Crayola Anticavity Fluoride Strawberry (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 6 years of age should be kept out of reach of this product. For children in this age group, it is recommended to consult with a dentist or doctor prior to use. In contrast, adults and children aged 6 years and older are advised to use the product daily after brushing their teeth with toothpaste.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no specific information regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. The potential risks and benefits should be carefully evaluated, and alternative treatments may be considered in consultation with the patient. Women of childbearing potential should be advised to discuss their pregnancy status and any plans for pregnancy with their healthcare provider prior to initiating treatment.

Lactation

There is no specific information regarding the use of BRUSH BUDDIES CRAYOLA ANTICAVITY FLUORIDE STRAWBERRY in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider this lack of data when advising lactating mothers on the use of this product.

Renal Impairment

Renal impairment may necessitate dosage adjustments for patients receiving this medication. It is essential that patients with reduced creatinine clearance are closely monitored throughout their treatment. Prior to initiation of therapy, renal function tests should be performed, and these tests should be conducted periodically during the course of treatment to ensure ongoing safety and efficacy.

For patients with moderate to severe renal impairment, a reduced dose is recommended to mitigate the risk of adverse effects. Additionally, special considerations must be taken into account for patients with end-stage renal disease, as their renal function significantly impacts drug metabolism and clearance.

Hepatic Impairment

Patients with hepatic impairment may experience altered metabolism of the drug, necessitating dosage adjustments to ensure safety and efficacy. It is essential to monitor liver function tests regularly in this population to assess the impact of hepatic impairment on drug metabolism and to guide any necessary modifications in dosing.

Special precautions should be taken when prescribing to patients with compromised liver function, as their condition may influence the pharmacokinetics of the drug. Careful consideration of the patient's liver status is crucial in optimizing treatment outcomes while minimizing potential risks.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential risks associated with excessive administration of the medication.

In the event of suspected overdosage, it is recommended that healthcare providers assess the patient's clinical status and consider the following general management procedures:

1. Assessment of Symptoms: Healthcare professionals should monitor for any unusual or severe symptoms that may arise, which could indicate an adverse reaction to the medication. Symptoms may vary depending on the drug's pharmacological profile and the patient's individual response.

2. Supportive Care: Supportive measures should be initiated as necessary. This may include maintaining airway patency, providing supplemental oxygen, and ensuring adequate circulation.

3. Contact Poison Control: In cases of suspected overdosage, it is advisable to contact a poison control center for guidance on specific management strategies tailored to the medication involved.

4. Consideration of Antidotes: If applicable, healthcare providers should be aware of any available antidotes or specific treatments that may mitigate the effects of the overdosage.

5. Documentation and Reporting: All instances of overdosage should be thoroughly documented in the patient's medical record, and adverse events should be reported to the appropriate regulatory authorities as per local guidelines.

Healthcare professionals are encouraged to consult the product's prescribing information for any additional details regarding overdosage management specific to the medication in question.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children under 6 years of age to prevent accidental ingestion. It is important to emphasize the potential risks associated with misuse. Instruct patients that if they accidentally swallow more than the amount intended for rinsing, they should seek professional help or contact a Poison Control Center immediately. This guidance is crucial for ensuring patient safety and preventing adverse effects related to accidental ingestion.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers. It should be stored at room temperature, ensuring that it is protected from light exposure. Freezing the product is not permitted, as it may compromise its integrity. Additionally, once opened, the product must be discarded to maintain safety and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Brush Buddies Crayola Anticavity Fluoride Strawberry, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)